References
- Aksenova AV, Elfimova EM, Litvin AY, Chazova IE. 2016. Chronotherapy’s opportunities of a fixed combination of perindopril 10 mg/indapamide 2.5 mg in patients with a lack of night reduction in blood pressure. Systemic Hypertens. 13:37–45. doi:https://doi.org/10.26442/SG29137
- Balan H. (2009). Bedtime versus at awakening administration of BP lowering drugs – Is it the way to success? Rom J Intern Med. 47:355–361. PMID: 21179917.
- Baraldo M. 2008. The influence of circadian rhythyms on the kinetics of drugs in humans. Expert Opin Drug Metab Toxicol. 4:175–192. doi: https://doi.org/10.1517/17425255.4.2.175
- Beliaev SD, Zaslavskaia RM, and Khetagurova LG. 2003. Optimization of sanatorium treatment of patients with essential hypertension stage II by chronotherapy. Klin Med (Mosk). 81:46–50. PMID: 14689711.
- Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. 2007. Predictors of all-cause mortality in clinical ambulatory monitoring. Unique aspects of blood pressure during sleep. Hypertension 49:1235–1241. doi:https://doi.org/10.1161/HYPERTENSIONAHA.107.087262
- Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund-Bodegård K, Richart T, Ohkubo T, Kuznetsova T, Torp-Pedersen CH, et al. 2007. Prognostic accuracy of day versus night ambulatory blood pressure: A cohort study. Lancet. 370:1219–1229. doi:https://doi.org/10.1016/S0140-6736(07)61538-4
- Bowles NP, Thosar SS, Herzig MX, Shea SA. 2018. Chronotherapy for hypertension. Curr Hypertens Rep. 20:97. doi:https://doi.org/10.1007/s11906-018-0897-4
- Charlson ME, de Moraes CG, Link A, Wells MT, Harmon G, Peterson JC, Ritch R, Liebmann JM. 2014. Nocturnal systemic hypotension increases the risk of glaucoma progression. Ophthalmology. 121:2004–2012. doi:https://doi.org/10.1016/j.ophtha.2014.04.016
- De Giorgi A, Menegatti AM, Fabbian F, Portaluppi F, Manfredini R. 2013. Circadian rhythms and medical diseases: Does it matter when drugs are taken? Eur J Intern Med. 24:698–706. doi:https://doi.org/10.1016/j.ejim.2013.03.019
- Egger M, Smith GD, Schneider M, Minder C. 1997. Bias in meta-analysis detected by a simple, graphical test. BMJ. 315:629–634. doi:https://doi.org/10.1136/bmj.315.7109.629
- Fabbian F, Smolensky MH, Tiseo R, Pala M, Manfredini R, Portaluppi F. 2013. Dipper and non-dipper blood pressure 24-hour patterns: Circadian rhythm-dependent physiologic and pathophysiologic mechanisms. Chronobiol Int. 30:17–30. doi:https://doi.org/10.3109/07420528.2012.715872
- Flack JM, Nasser SA. 2011. Benefits of once-daily therapies in the treatment of hypertension. Vasc Health Risk Manag. 7:777–787. doi:https://doi.org/10.2147/VHRM.S17207
- Fujiwara T, Hoshide S, Yano Y, Kanegae H, Kario K. 2017. Comparison of morning vs bedtime administration of the combination of valsartan/amlodipine on nocturnal brachial and central blood pressure in patients with hypertension. J Clin Hypertens (Greenwich). 19:1319–1326. doi:https://doi.org/10.1111/jch.13128
- Gupta R, Malik AH, Popli T, Ranchal P, Yandrapalli S, and Aronow WS. 2021. Impact of bedtime dosing of antihypertensives compared to morning therapy: A meta-analysis of randomised controlled trials. Eur J Prev Cardiol. 2021;28:e5–e8. doi:https://doi.org/10.1177/2047487320903611
- Gupta R, Malik AH, Popli T, Ranchal P, Yandrapalli S, and Aronow WS. 2020. Impact of bedtime dosing of antihypertensives compared to morning therapy: A meta-analysis of randomised controlled trials. Eur J Prev Cardiol 28 e5–e8 . doi:https://doi.org/10.1177/2047487320903611. Epub ahead of print.
- Hermida RC, Ayala DE. 2016. Ambulatory blood pressure, chronotherapy of hypertension and glaucoma. Med Clin (Barc). 146:30–34. doi:https://doi.org/10.1016/j.medcli.2015.05.013
- Hermida RC, Ayala DE, Fontao MJ, Mojón A, Fernández JR. 2010a. Chronotherapy with valsartan/amlodipine fixed combination: Improved blood pressure control of essential hypertension with bedtime dosing. Chronobiol Int. 27:1287–1303. doi:https://doi.org/10.3109/07420528.2010.489167
- Hermida RC, Ayala DE, Mojón A, Fernández JR. 2010b. Influence of circadian time of hypertension treatment on cardiovascular risk: Results of the MAPEC study. Chronobiol Int. 27:1629–1651. doi:https://doi.org/10.3109/07420528.2010.510230
- Hermida RC, Ayala DE, Mojón A, Fernández JR. 2011a. Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J Am Coll Cardiol. 58:1165–1173. doi:https://doi.org/10.1016/j.jacc.2011.04.043
- Hermida RC, Ayala DE, Mojón A, Fontao MJ, Fernández JR. 2011b. Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: Improved sleep-time blood pressure control with bedtime dosing. Chronobiol Int. 28:601–610. doi:https://doi.org/10.3109/07420528.2011.589935
- Hermida RC, Ayala DE, Portaluppi F. 2007. Circadian variation of blood pressure: The basis for the chronotherapy of hypertension. Adv Drug Deliv Rev. 59:904–922. doi:https://doi.org/10.1016/j.addr.2006.08.003
- Hermida RC, Ayala DE, Smolensky MH, Fernández JR, Mojón A, Portaluppi F. 2016. Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks. Hypertens Res. 39:277–292. doi:https://doi.org/10.1007/s00125-015-3748-8
- Hermida RC, Ayala DE, Smolensky MH, Fernández JR, Mojón A, Portaluppi F. 2017. Sleep-time blood pressure: Unique sensitive prognostic marker of vascular risk and therapeutic target for prevention. Sleep Med Rev. 33:17–27. doi:https://doi.org/10.1016/j.smrv.2016.04.001
- Hermida RC, Crespo JJ, Domínguez-Sardiña M, Otero A, Moyá A, Ríos MT, Sineiro E, Castiñeira MC, Callejas PA, Pousa L, et al. 2020a. Bedtime hypertension treatment improves cardiovascular risk reduction: The Hygia Chronotherapy Trial. Eur Heart J. 41:4565–4576. doi:https://doi.org/10.1093/eurheartj/ehz754
- Hermida RC, Crespo JJ, Otero A, Domínguez-Sardiña M, Moyá A, Ríos MT, Castiñeira MC, Callejas PA, Pousa L, Sineiro E, et al. 2018. Asleep blood pressure: Significant prognostic marker of vascular risk and therapeutic target for prevention. Eur Heart J. 39:4159–4171. doi:https://doi.org/10.1093/eurheartj/ehy475
- Hermida RC, Hermida-Ayala RG, Mojón A, Smolensky MH, Fernández JR. 2021a. Systematic review and quality evaluation of published human ingestion-time trials of blood pressure-lowering medications and their combinations. Chronobiol Int. 38:10:1460–1476. doi:https://doi.org/10.1080/07420528.2021.1931280
- Hermida RC, Hermida-Ayala RG, Smolensky MH, Mojón A, Crespo JJ, Otero A, Ríos MT, Domínguez-Sardiña M, Fernández JR 2020b. Does timing of antihypertensive medication dosing matter? Curr Cardiol Rep. 22(118). doi:https://doi.org/10.1007/s11886-020-01353-7
- Hermida RC, Hermida-Ayala RG, Smolensky MH, Mojón A, Fernández JR. 2020c. Chronopharmacology of hypertension medications: Impact of ingestion-time on pharmacokinetics and pharmacodynamics. Exp Opin Drug Metab Toxicol. 16:1159–1173. doi:https://doi.org/10.1080/17425255.2020.1825681
- Hermida RC, Hermida-Ayala RG, Smolensky MH, Mojón A, Fernández JR. 2021b. Ingestion-time differences in the pharmacodynamics of hypertension medications: Systematic review of human chronopharmacology trials. Adv Drug Deliv Rev. 170:200–213. doi:https://doi.org/10.1016/j.addr.2021.01.013
- Hermida RC, Mojón A, Fernández JR, Hermida-Ayala RG, Crespo JJ, Ríos MT, Domínguez-Sardiña M, Otero A, Smolensky MH. 2021c. Elevated asleep blood pressure and non-dipper 24h patterning best predict risk for heart failure that can be averted by bedtime hypertension chronotherapy: A review of the published literature. Chronobiol Int. 1–20. doi:https://doi.org/10.1080/07420528.2021.1939367. Epub ahead of print
- Hermida RC, Mojón A, Fernández JR, Otero A, Crespo JJ, Domínguez-Sardiña M, Ríos MT, Smolensky MH. 2020d. Ambulatory blood pressure monitoring-based definition of true arterial hypertension. Minerva Med. 111:573–588. doi:https://doi.org/10.23736/S0026-4806.20.06834-2
- Hermida RC, Mojón A, Hermida-Ayala RG, Smolensky MH, Fernández JR. 2021d. Extent of asleep blood pressure reduction by hypertension medications is ingestion-time dependent: Systematic review and meta-analysis of published human trials. Sleep Med Rev. 59:101454. doi:https://doi.org/10.1016/j.smrv.2021.101454
- Hermida RC, Mojón A, Smolensky MH, Fernández JR. 2021e. Lowering nighttime blood pressure with bedtime dosing of antihypertensive medications: Controversies in hypertension – Pro side of the argument. Hypertension. 78:879–893. doi:https://doi.org/10.1161/HYPERTENSIONAHA.120.16500
- Hermida RC, Smolensky MH, Ayala DE, Portaluppi F, Crespo JJ, Fabbian F, Haus E, Manfredini R, Mojón A, Moyá A, et al. 2013. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals. Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM). Chronobiol Int. 30:355–410. doi:https://doi.org/10.3109/07420528.2013.750490
- Hermida RC, Smolensky MH, Balan H, Castriotta RJ, Crespo JJ, Dagan Y, El-Toukhy S, Fernández JR, FitzGerald GA, Fujimura A, et al. 2021f. Guidelines for the design and conduct of human clinical trials on ingestion-time differences – Chronopharmacology and chronotherapy – Of hypertension medications. Chronobiol Int. 38:1–26. doi:https://doi.org/10.1080/07420528.2020.1850468
- Hoshino A, Nakamura T, Matsubara H. 2010. The bedtime administration ameliorates blood pressure variability and reduces urinary albumin excretion in amlodipine-olmesartan combination therapy. Clin Exp Hypertens. 32:416–422. doi:https://doi.org/10.3109/10641961003667948
- Huangfu W, Duan P, Xiang D, and Gao R. 2015. Administration time-dependent effects of combination therapy on ambulatory blood pressure in hypertensive subjects. Int J Clin Exp Med. 8:19156–19161. PMID: 26770548.
- Kario K, Hoshide S, Uchiyama K, Yoshida T, Okazaki O, Noshiro T, Aoki H, Mizuno H, Matsumoto Y. 2016. Dose timing of an angiotensin II receptor blocker/calcium channel blocker combination in hypertensive patients with paroxysmal atrial fibrillation. J Clin Hypertens (Greenwich). 18:1036–1044. doi:https://doi.org/10.1111/jch.12814
- Krasinska B, Karolczak-Kulesza M, Krasinski Z, Pawlaczyk-Gabriel K, Lopatka P, Gluszek J, Tykarski A. 2012. Effects of the time of antihypertensive drugs administration on the stage of primary open-angle glaucoma in patients with arterial hypertension. Blood Press. 21:240–248. doi:https://doi.org/10.3109/08037051.2012.666423
- Liu X, Liu X, Huang W, Leo S, Li Y, Liu M, Yuan H. 2014. Evening – Versus morning – Dosing drug therapy for chronic kidney disease patients with hypertension: A systematic review. Kidney Blood Press Res. 39:427–440. doi:https://doi.org/10.1159/000368456
- Martino TA, Tata N, Simpson JA, Vanderlaan R, Dawood F, Kabir MG, Khaper N, Cifelli C, Podobed P, Liu PP, et al. 2011. The primary benefits of angiotensin-converting enzyme inhibition on cardiac remodeling occur during sleep time in murine pressure overload hypertrophy. J Am Coll Cardiol. 57:2020–2028. doi:https://doi.org/10.1016/j.jacc.2010.11.022
- Meng Y, Zhang Z, Liang X, Wu C, Qi G. 2010. Effects of combination therapy with amlodipine and fosinopril administered at different times on blood pressure and circadian blood pressure pattern in patients with essential hypertension. Acta Cardiol. 65:309–314. doi:https://doi.org/10.2143/AC.65.3.2050347
- Middeke M, Klüglich M, Holzgreve H. 1991. Chronopharmacology of captopril plus hydrochlorothiazide in hypertension: Morning versus evening dosing. Chronobiol Int. 8:506–510. doi:https://doi.org/10.3109/07420529109059186
- Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. 2009. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann Intern Med. 151:264–269. doi:https://doi.org/10.7326/0003-4819-151-4-200908180-00135
- National Institute for Health and Clinical Excellence. 2019. Hypertension in adults: Diagnosis and management. NICE Guideline 136: Methods, evidence and recommendations. National Clinical Guidelines Centre, London, UK. Available from: https://www.nice.org.uk/guidance/ng136 [last accessed 15 August 2021].
- Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, et al. 2002. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: The Ohasama study. J Hypertens. 20:2183–2189. doi:https://doi.org/10.1097/00004872-200211000-00017
- Okeahialam BN, Ohihoin EN, Ajuluchukwu JN. 2012. Diuretic drugs benefit patients with hypertension more with night-time dosing. Ther Adv Drug Saf. 3:273–278. doi:https://doi.org/10.1177/2042098612459537
- Peng GC, Wang YF, Xiao Y, Chen JF, Yang Y, Ye YL, Sai SQ, Huang JX. (2013). Blood pressure lowering efficacy of telmisartan and amlodipine taking on the morning or at bedtime: ABPM results. Zhonghua Xin Xue Guan Bing Za Zhi. 41:484–487. PMID: 24113040.
- Portaluppi F, Tiseo R, Smolensky MH, Hermida RC, Ayala DE, Fabbian F. 2012. Circadian rhythms and cardiovascular health. Sleep Med Rev. 16:151–166. doi:https://doi.org/10.1016/j.smrv.2011.04.003
- Roush GC, Fagard RH, Salles GF, Pierdomenico SD, Reboldi G, Verdecchia P, Eguchi K, Kario K, Hoshide S, Polonia J, et al. 2014a. Prognostic impact from clinic, daytime, and nighttime systolic blood pressure in 9 cohorts on 13,844 patients with hypertension. J Hypertens. 32:2332–2340. doi:https://doi.org/10.1097/HJH.0000000000000355
- Roush GC, Fapohunda J, Kostis JB. 2014b. Evening dosing of antihypertensive therapy to reduce cardiovascular events: A third type of evidence based on a systematic review and meta-analysis of randomized trials. J Clin Hypertens (Greenwich). 16:561–568. doi:https://doi.org/10.1111/jch.12354
- Salles GF, Reboldi G, Fagard RH, Cardoso C, Pierdomenico SD, Verdecchia P, Eguchi K, Kario K, Hoshide S, Polonia J, et al. 2016. Prognostic impact of the nocturnal blood pressure fall in hypertensive patients: The ambulatory blood pressure collaboration in patients with hypertension (ABC-H) meta-analysis. Hypertension. 67:693–700. doi:https://doi.org/10.1161/HYPERTENSIONAHA.115.06981
- Schillaci G, Battista F, Settimi L, Schillaci L, Pucci G. 2015. Antihypertensive drug treatment and circadian blood pressure rhythm: A review of the role of chronotherapy in hypertension. Curr Pharm Des. 21:756–772. doi:https://doi.org/10.2174/1381612820666141024130013
- Skibitsky VV, Fendrikova AV, Opolskaya SV. 2018. Comparison of influence of various regimens of drug intake on 24 hour blood pressure, central aortic pressure and vascular wall stiffness in systemic hypertension patients with ischemic stroke. Russ J Cardiol. 4:56–66. doi:https://doi.org/10.15829/1560-4071-2018-4-56-66
- Skibitsky VV, Fendrikova AV, Opolskaya SV. 2019. Antihypertensive and vasoprotective effectiveness of the chronopharmacotherapy in patients with arterial hypertension after acute cerebrovascular accident. Kardiologiia. 59:25–33. doi:https://doi.org/10.18087/cardio.2537
- Skibitsky VV, Fendrikova AV, Sirotenko DV, Skibitskiy AV. 2016. Chronotherapy aspects of efficiency azilsartan medoxomil in combination therapy in patients with hypertension and metabolic syndrome. Kardiologiia. 56:35–40. doi:https://doi.org/10.18565/cardio.2016.10.35-40
- Smolensky MH, Hermida RC, Castriotta RJ, Portaluppi F. 2007. Role of sleep-wake cycle on blood pressure circadian rhythms and hypertension. Sleep Med. 8:668–680. doi:https://doi.org/10.1016/j.sleep.2006.11.011
- Smolensky MH, Hermida RC, Portaluppi F. 2017. Circadian mechanisms of 24-hour blood pressure regulation and patterning. Sleep Med Rev. 33:4–16. doi:https://doi.org/10.1016/j.smrv.2016.02.003
- Sole MJ, Martino TA. 2009. Diurnal physiology: Core principles with application to the pathogenesis, diagnosis, prevention, and treatment of myocardial hypertrophy and failure. J Appl Physiol. 107:1318–1327. doi:https://doi.org/10.1152/japplphysiol.00426.2009
- Sun Y, Yu X, Liu J, Zhou N, Chen L, Zhao Y, Li X, Wang J, Cui L. 2016. Effect of bedtime administration of blood-pressure lowering agents on ambulatory blood pressure monitoring results: A meta-analysis. Cardiol J. 23:473–481. doi:https://doi.org/10.5603/CJ.a2016.0027
- Tokunaga T, Kashiwagi K, Tsumura T, Taguchi K, Tsukahara S. 2004. Association between nocturnal blood pressure reduction and progression of visual field defect in patients with primary open-angle glaucoma or normal-tension glaucoma. Jpn J Ophthalmol. 48:380–385. doi:https://doi.org/10.1007/s10384-003-0071-6
- Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS, Tomaszewski M, et al. 2020. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension. 75:1334–1357. doi:https://doi.org/10.1161/HYPERTENSIONAHA.120.15026
- Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. 2008. Adherence to prescribed antihypertensive drug treatments: Longitudinal study of electronically compiled dosing histories. BMJ. 336:1114–1117. doi:https://doi.org/10.1136/bmj.39553.670231.25
- Werne A, Harris A, Moore D, BenZion I, Siesky B. 2008. The circadian variations in systemic blood pressure, ocular perfusion pressure, and ocular blood flow: Risk factors for glaucoma? Surv Ophthalmol. 53:559–567. doi:https://doi.org/10.1016/j.survophthal.2008.08.021
- Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Himmerfarb CD, DePalma SM, Gidding S, Jamerson KA, Jones DW, et al. 2018. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 71:e127–e248. doi: https://doi.org/10.1016/j.jacc.2017.11.006.
- Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, et al. 2018. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 39:3021–3104. doi:https://doi.org/10.1093/eaurheartj/ehy339
- Zeng J, Jia M, Ran H, Tang H, Zhang Y, Zhang J, Wang X, Wang H, Yang C, Zeng C. 2011. Fixed-combination of amlodipine and diuretic chronotherapy in the treatment of essential hypertension: Improved blood pressure control with bedtime dosing–a multicenter, open-label randomized study. Hypertens Res. 34:767–772. doi:https://doi.org/10.1038/hr.2011.36
- Zhao P, Xu P, Wan C, Wang Z 2011. Evening versus morning dosing regimen drug therapy for hypertension. Cochrane Database Syst Rev. 10(CD004184). doi:https://doi.org/10.1002/14651858.CD004184.pub2